Phibro Animal Health | PAHC - Operating Profit


Phibro Animal Health reported $25.53M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Align Technology USD 224.71M 40.06M Dec/2025
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Assertio Holdings USD -3.05M 569K Sep/2024
Aurora Cannabis CAD -55.67M 35.45M Sep/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Canopy Growth CAD -14.3M 3.18M Sep/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Henry Schein USD 186M 12M Dec/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Merck USD 6.24B 318M Dec/2025
Nektar Therapeutics USD -34.34M 15.43M Sep/2024
Pacira USD 3.19M 9.96M Dec/2025
Phibro Animal Health USD 25.53M 7.83M Dec/2024
Prestige Brands USD 82.49M 2.82M Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
Zoetis USD 835M 101M Dec/2025